ProPhase Labs (PRPH) said late Wednesday it intends to explore the acquisition of one or more Clinical Laboratory Improvement Amendment accredited labs suitable for COVID-19 and other testing.
To assist with this process, the company has entered into a deal with industry expert, Predictive Laboratories, to help identify new opportunities in the medical technology and testing fields.
In addition, ProPhase Labs amended a promissory note and security agreement with Predictive Labs before loaning in $3 million.
Sounds like something big is brewing in PRED land.
Market Data 
Markets 
AI
